1. Home
  2. FRPH vs RAPP Comparison

FRPH vs RAPP Comparison

Compare FRPH & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRPH
  • RAPP
  • Stock Information
  • Founded
  • FRPH 1986
  • RAPP 2022
  • Country
  • FRPH United States
  • RAPP United States
  • Employees
  • FRPH N/A
  • RAPP N/A
  • Industry
  • FRPH Real Estate
  • RAPP
  • Sector
  • FRPH Finance
  • RAPP
  • Exchange
  • FRPH Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • FRPH 521.1M
  • RAPP 463.8M
  • IPO Year
  • FRPH N/A
  • RAPP 2024
  • Fundamental
  • Price
  • FRPH $26.88
  • RAPP $10.15
  • Analyst Decision
  • FRPH
  • RAPP Strong Buy
  • Analyst Count
  • FRPH 0
  • RAPP 5
  • Target Price
  • FRPH N/A
  • RAPP $35.00
  • AVG Volume (30 Days)
  • FRPH 59.4K
  • RAPP 259.3K
  • Earning Date
  • FRPH 05-07-2025
  • RAPP 05-10-2025
  • Dividend Yield
  • FRPH N/A
  • RAPP N/A
  • EPS Growth
  • FRPH 20.77
  • RAPP N/A
  • EPS
  • FRPH 0.34
  • RAPP N/A
  • Revenue
  • FRPH $30,415,000.00
  • RAPP N/A
  • Revenue This Year
  • FRPH N/A
  • RAPP N/A
  • Revenue Next Year
  • FRPH N/A
  • RAPP N/A
  • P/E Ratio
  • FRPH $79.49
  • RAPP N/A
  • Revenue Growth
  • FRPH 2.86
  • RAPP N/A
  • 52 Week Low
  • FRPH $25.37
  • RAPP $6.43
  • 52 Week High
  • FRPH $33.00
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • FRPH 39.03
  • RAPP N/A
  • Support Level
  • FRPH $26.46
  • RAPP N/A
  • Resistance Level
  • FRPH $27.96
  • RAPP N/A
  • Average True Range (ATR)
  • FRPH 1.16
  • RAPP 0.00
  • MACD
  • FRPH -0.03
  • RAPP 0.00
  • Stochastic Oscillator
  • FRPH 34.95
  • RAPP 0.00

About FRPH FRP Holdings Inc.

FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: